Shree Ganesh Remedies Intrinsic Value
Shree Ganesh Remedies intrinsic value. Shree Ganesh Remedies (SGRL) median intrinsic value is ₹272.16 from 9 valuation models (range ₹204–₹429), vs current price ₹680.40 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Read SGRL dividend growth for the complete payout history and dividend yield track record.
SGRL Valuation Methods Summary — DCF, Graham Number & P/E
Shree Ganesh Remedies intrinsic value across 9 models vs current price ₹680.40 — upside/downside and value range per method. For current market price and key ratios, visit SGRL share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹429.44 | ₹343.55 - ₹515.33 | -36.9% | EPS: ₹19.52, Sector P/E: 22x |
| Book Value Method | asset | ₹250.77 | ₹225.69 - ₹275.85 | -63.1% | Book Value/Share: ₹125.38, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹209.23 | ₹188.31 - ₹230.15 | -69.2% | Revenue/Share: ₹104.62, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹369.23 | ₹332.31 - ₹406.15 | -45.7% | EBITDA: ₹48.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹272.16 | ₹217.73 - ₹326.59 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹204.12 | ₹183.71 - ₹224.53 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹301.58 | ₹271.42 - ₹331.74 | -55.7% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹340.20 | ₹306.18 - ₹374.22 | -50.0% | ROE: 14.7%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹234.67 | ₹211.20 - ₹258.14 | -65.5% | EPS: ₹19.52, BVPS: ₹125.38 |
SGRL Intrinsic Value vs Market Price — All Valuation Models
Shree Ganesh Remedies fair value range ₹204–₹429 vs current market price ₹680.40 across 9 valuation models. Compare with Shree Ganesh Remedies valuation methods to assess whether the stock is under or overvalued.
SGRL Intrinsic Value Analysis — Undervalued or Overvalued?
Shree Ganesh Remedies median intrinsic value ₹272.16, current price ₹680.40 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of SGRL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Shree Ganesh Remedies (SGRL) is ₹272.16 (median value). With the current market price of ₹680.40, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹204.12 to ₹429.44, indicating ₹204.12 - ₹429.44.
Is SGRL undervalued or overvalued?
Based on our multi-method analysis, Shree Ganesh Remedies (SGRL) appears to be trading above calculated value by approximately 60.0%.
SGRL Financial Health — Key Ratios vs Industry Benchmarks
Shree Ganesh Remedies financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.74 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 14.7% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 34.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.65x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
SGRL Cash Flow Quality — Operating & Free Cash Flow
Shree Ganesh Remedies operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹24 Cr | ₹20 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹31 Cr | ₹13 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹31 Cr | ₹15 Cr | Positive Free Cash Flow | 7/10 |
| March 2020 | ₹5 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2019 | ₹-5 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |